155 related articles for article (PubMed ID: 7363513)
1. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.
Cordy PE
Can Med Assoc J; 1977 Oct; 117(7):766-8. PubMed ID: 907948
[TBL] [Abstract][Full Text] [Related]
3. [Effect of dihydrotachysterol on bone tissue in rats with experimental kidney failure].
Iagodovskiĭ VS; Ermolenko VM; Spirichev VB; Blazheevich NV; Migunova NA
Biull Eksp Biol Med; 1980 Nov; 90(11):611-3. PubMed ID: 7448398
[TBL] [Abstract][Full Text] [Related]
4. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
[No Abstract] [Full Text] [Related]
5. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
[No Abstract] [Full Text] [Related]
6. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
Van Kesteren RG; Duursma SA; Dorhout Mees EJ
Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
[No Abstract] [Full Text] [Related]
7. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
[No Abstract] [Full Text] [Related]
8. [Treatment of renal osteodystrophy].
Duursma SA; Dorhout Mees EJ
Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
[No Abstract] [Full Text] [Related]
9. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
[No Abstract] [Full Text] [Related]
10. [Osteodystrophy in chronic renal insufficiency. Clinical, histologic, radiologic and radioisotope study].
Rimondi C; Monetti N; Bellanova B; Zucchelli P; Fusaroli M; Fabbri L; Trenta A; Pavlica P; Viglietta G
J Radiol Electrol Med Nucl; 1975; 56 suppl 1():346. PubMed ID: 1232209
[No Abstract] [Full Text] [Related]
11. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
[TBL] [Abstract][Full Text] [Related]
12. Radiological/pathological correlations in uremic bone disease.
Debnam JW; Bates ML; Kopelman RC; Teitelbaum SL
Radiology; 1977 Dec; 125(3):653-8. PubMed ID: 928689
[TBL] [Abstract][Full Text] [Related]
13. A model for clinical research studies of renal osteodystrophy in children.
Norman ME; Mazur A; Gruskin AB
Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
[No Abstract] [Full Text] [Related]
14. [Effect of dihydrotachysterol in the treatment and prevention of uremic osteopathy in children].
Sieniawska M; Białasik D
Pediatr Pol; 1981 Jul; 56(7):733-41. PubMed ID: 7301469
[No Abstract] [Full Text] [Related]
15. Changing manifestations of brown tumors on bone scan in renal osteodystrophy.
Brown WT; Lyons KP; Winer RL
J Nucl Med; 1978 Oct; 19(10):1146-8. PubMed ID: 722326
[TBL] [Abstract][Full Text] [Related]
16. 1,25(OH)2D levels in dihydrotachysterol-treated patients: influence on 1,25(OH)2D assays.
Taylor A; Norman ME
J Bone Miner Res; 1987 Dec; 2(6):567-70. PubMed ID: 2844067
[TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
Pierides AM; Ellis HA; Dellagrammatikas H; Scott JE; Norman AW
Arch Dis Child; 1977 Jun; 52(6):464-72. PubMed ID: 879832
[TBL] [Abstract][Full Text] [Related]
18. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
Pogglitsch H; Schmidberger H; Gell G
MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
[TBL] [Abstract][Full Text] [Related]
19. [Evolving aspects of uremic osteodystrophy in the dialized patient].
Zucchelli P; Fusaroli M; Fabbri L; Catizone L; Pavlica P; Viglietta G; Casanova S
J Urol Nephrol (Paris); 1976; 82(4-5):325-8. PubMed ID: 940176
[No Abstract] [Full Text] [Related]
20. [New viewpoints on the therapy and prevention of renal osteopathy].
Kaiser W; Mampel E
Z Gesamte Inn Med; 1977 Jun; 32(12):254-9. PubMed ID: 333796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
